COL1A1 and miR-29b show lower expression levels during osteoblast differentiation of bone marrow stromal cells from Osteogenesis Imperfecta patients

BMC Medical Genetics

Volumn 15, Issue 1, 2014, Pages

  Kaneto, Carla M ^a,d   Lima, Patrícia S P ^c   Zanette, Dalila L ^a,b   Prata, Karen L ^b   Pina Neto, João M ^a   de Paula, Francisco J A ^a   Silva, Wilson A ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b National Inst of Science and Technology in Cell Therapy   (Brazil)

^c UNIVERSIDADE ESTADUAL DO SUDOESTE DA BAHIA   (Brazil)

^d DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

Author keywords

COL1A1; Mesenchymalstem cells; miR 29b; Osteogenesis; Osteogenesis Imperfecta

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 1A1; COLLAGEN TYPE 1A2; MICRORNA 29B; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EXON; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENETIC CODE; HUMAN; HUMAN CELL; INTRON; MALE; MESENCHYMAL STEM CELL; MISSENSE MUTATION; OSTEOBLAST DIFFERENTIATION; OSTEOGENESIS IMPERFECTA; PHENOTYPE; SEQUENCE ANALYSIS; STROMA CELL;

ADOLESCENT; ADULT; CELL DIFFERENTIATION; COLLAGEN TYPE I; EXONS; FEMALE; GENE EXPRESSION; GENE ORDER; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICRORNAS; OSTEOBLASTS; OSTEOGENESIS IMPERFECTA; YOUNG ADULT;

EID: 84900524818     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-15-45     Document Type: Article

References (18)

1. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999, 5:309-313. 10.1038/6529, 10086387.
2. Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979, 16:101-116. 10.1136/jmg.16.2.101, 1012733, 458828.
3. Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet 2004, 363:1377-1385. 10.1016/S0140-6736(04)16051-0, 15110498.
4. Reuter MS, Schwabe GC, Ehlers C, Marschall C, Reis A, Thiel C, Graul-Neumann L. Two novel distinct COL1A2 mutations highlight the complexity of genotype-phenotype correlations in osteogenesis imperfecta and related connective tissue disorders. Eur J Med Genet 2013, 56:1-5. 10.1016/j.ejmg.2012.08.012, 23059468.
5. Pollitt R, McMahon R, Nunn J, Bamford R, Afifi A, Bishop N, Dalton A. Mutation analysis of COL1A1 and COL1A2 in patients diagnosed with osteogenesis imperfecta type I-IV. Hum Mutat 2006, 27:716.
6. Li Z, Hassan MQ, Jafferji M, Aqeilan RI, Garzon R, Croce CM, Van Wijnen AJ, Stein JL, Stein GS, Lian JB. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem 2009, 284:15676-15684. 10.1074/jbc.M809787200, 2708864, 19342382.
7. Schoolmeesters A, Eklund T, Leake D, Vermeulen A, Smith Q, Force Aldred S, Fedorov Y. Functional profiling reveals critical role for miRNA in differentiation of human mesenchymal stem cells. PloS One 2009, 4:e5605. 10.1371/journal.pone.0005605, 2680014, 19440384.
8. Li Z, Hassan MQ, Volinia S, Van Wijnen AJ, Stein JL, Croce CM, Lian JB, Stein GS. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A 2008, 105:13906-13911. 10.1073/pnas.0804438105, 2544552, 18784367.
9. Huang J, Zhao L, Xing LCD. MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 2010, 28:357-364. 2837600, 20039258.
10. Kapinas K, Kessler CB, Delany AM. miR-29 Suppression of Osteonectin in Osteoblasts: regulation during differentiation and by Canonical Wnt Signaling. J Cell Biochem 2010, 108:216-224.
11. Kim YJ, Bae SW, Yu SS, Bae YC, Jung JS. miR-196a regulates proliferation and osteogenic differentiation in Mesenchymal stem cells derived from human adipose tissue. J Bone Miner Res 2009, 24:816-825. 10.1359/jbmr.081230, 19063684.
12. Silva WA, Covas DT, Panepucci RA, Proto-Siqueira R, Siufi JL, Zanette DL, Santos ARZM. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 2003, 21:661-669. 10.1634/stemcells.21-6-661, 14595126.
13. Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone JR, Jaenisch R, Sharp PA, Jacks T. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008, 132:875-886. 10.1016/j.cell.2008.02.019, 2323338, 18329372.
14. Willing MC, Deschenes SP, Scott DA, Byers PH, Slayton RL, Pitts SH, Arikat H, Roberts EJ. Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen. Am J Hum Genet 1994, 55:638-647. 1918287, 7942841.
15. Goff LA, Boucher S, Ricupero CL, Fenstermacher S, Chase L, Adams C, Chesnut J, Lakshmipathy U, Hart RP. Differentiating human multipotent mesenchymal stromal cells regulate microRNAs: prediction of microRNA regulation by PDGF during osteogenesis. Exp Hematol 2009, 36:1354-1369.
16. Suh EJ, Remillard MY, Legesse-Miller A, Johnson EL, Lemons JM, Chapman TR, Forman JJ, Kojima M, Silberman ES, Coller HA. A microRNA network regulates proliferative timing and extracellular matrix synthesis during cellular quiescence in fibroblasts. Genome Biol 2012, 13:R121. 10.1186/gb-2012-13-12-r121, 3924601, 23259597.
17. Sakai D, Mochida J, Yamamoto Y, Nomura T, Okuma M, Nishimura K, Nakai T, Ando K, Hotta T. Transplantation of mesenchymal stem cells embedded in Atelocollagen® gel to the intervertebral disc: a potential therapeutic model for disc degeneration. Biomaterials 2003, 24:3531-3541. 10.1016/S0142-9612(03)00222-9, 12809782.
18. Breslau-Siderius EJ, Engelbert RH, van der Pals G SJ. Bruck syndrome: a rare combination of bone fragility and multiple congenital joint contractures. J Pediatr Orthop 1998, 7:35-38.